BioAge Labs Insider Trades Show Confidence: CFO Buys Low, CEO Sells High, Pipeline Persists
BioAge Labs insider trades reveal a mix of liquidity moves and bullish buying—CFO buys at $8.39 while CEO sells at $18.12, signaling confidence in its aging‑disease pipeline.
4 minutes to read